Chargement en cours...
Quantification of apixaban in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry
Apixaban, an inhibitor of direct factor Xa, is used for the treatment of venous thromboembolic events or prevention of stroke. Unlike many other anticoagulant agents, it does not need periodic monitoring. However, monitoring is still required to determine the risk of bleeding due to overdose or surg...
Enregistré dans:
| Publié dans: | Transl Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Korean Society for Clinical Pharmacology and Therapeutics
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6989270/ https://ncbi.nlm.nih.gov/pubmed/32055579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2019.27.1.33 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|